MY006

Indicaton

Human antibody product against major peanut allergens to treat peanut allergy via
passive immunization. In contrast to active immunotherapy, anti-allergen therapy
circumvents allergen exposure, making it a safe and immediately active treatment for patients.

Therapeutic indications

Immunology

Type of product

Antibody

Table

Phase

Discovery
Partnering status

Not partnered

You may also be interested in

3D CoSeedis in chip Assays

Preclinical 3D Study models for oncology and neurology.

Marketed

MY010

Human antibody product against major birch and birch-related allergens to treat pollen allergy via anti-allergen therapy.

Discovery

nextaro

With the nextaro® product line we have set a new quality benchmark for the reconstitution of lyophilized pharmaceuticals. We created our transfer devices based on demands from the market, leading the field when it comes to safety, stability, haptics, handling and quality.
https://www.nextaro.com/en/